Dexcom, Inc. share price logo

Dexcom, Inc. Share Price

NASDAQ: DXCM

Large Cap

$65.50

+0.25

(+0.38%)

as on

Dexcom, Inc. Stock Performance

as on December 6, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $65.23
    $66.75
    downward going graph

    0.41%

    Downside

    1.91%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $54.11
    $93.25
    downward going graph

    17.39%

    Downside

    42.37%

    Upside

    downward going graph

Dexcom, Inc. share price movements today

Previous Close
$65.25
Open
$65.42
Volume
2.9M
Day's Low - High
$65.23 - $66.75
52 Week Low - High
$54.11 - $93.25

Dexcom, Inc. Historical Returns

1 Month Return
+ 12.87 %
3 Month Return
-18.66 %
1 Year Return
-15.74 %
3 Year Return
-43.94 %
5 Year Return
-24.73 %

Dexcom, Inc. Stock Fundamentals & Key Indicators

Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$25.7B

EPS (TTM)

2.0661

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.10%

PE Ratio (TTM)

36.38

Industry PE ratio

19.200384615384614

PEG Ratio

0.8527

EBITDA

1.0B

Revenue (TTM)

4.5B

Profit Margin

15.96%

Return On Equity TTM

30.64%

Dexcom, Inc. Stock Valuation

Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.

Dexcom, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (46.86x)

December 31, 2024

Industry (19.20x)

December 6, 2025

Today (36.38x)

December 6, 2025

Highest (175.15x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 36.38x

Dexcom, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$25.7B-24.73%36.3815.96%
BUY$144.9B183.41%52.2614.43%
BUY$139.3B51.93%47.8812.07%
BUY$130.8B-10.97%27.6413.71%
BUY$218.3B15.92%15.7531.88%

Stock Returns calculator for Dexcom, Inc. Stock including INR - Dollar returns

The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dexcom, Inc. investment value today

Current value as on today

₹90,434

Returns

₹9,566

(-9.57%)

Returns from Dexcom, Inc. Stock

₹15,723 (-15.72%)

Dollar Returns*

₹6,157 (+6.16%)

Analyst Recommendation on Dexcom, Inc. Stock

Based on 30 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $84.77

Dexcom, Inc. Share Price Target

Get share price movements and forecasts by analysts on Dexcom, Inc..

What analysts predicted

22.73%UPSIDE

Target Price

$84.77

Current Price

$65.5

Analyzed by

30 Analysts

Target

$84.77

Dexcom, Inc. target price $84.77, a slight upside of 22.73% compared to current price of $65.5. According to 30 analysts rating.

Dexcom, Inc. Stock’s Investor Sentiment and Interest

Investment in Dexcom, Inc. Shares on INDmoney has dropped by -59.28% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-59.28% versus previous 30 day period

Search interest for Dexcom, Inc. Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:53% versus previous 30 day period

Dexcom, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
871
975
1,034
921
1,004
994
1,113
1,036
1,157
1,209
Gross Profit
546
623
656
561
626
593
655
589
688
731
Operating Income
128
205
216
101
158
152
188
133
212
242
EBITDA
208
293
303
189
244
237
274
219
308
415
Interest Expense
5
4
4
4
4
4
4
4
4
4
Depreciation
1
1
52
52
52
55
57
60
63
63
Income Before Tax
159
240
246
132
187
177
211
154
241
352
Income Tax Expense
43
119
-10
-13
44
42
59
48
61
68
Net Income
115
120
256
146
143
134
151
105
179
283
Net Profit Margin
13.30%
12.38%
24.78%
15.90%
14.29%
13.54%
13.62%
10.17%
15.54%
23.47%

Dexcom, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
402
573
718
1,031
1,476
1,926
2,448
2,909
3,622
4,033
Gross Profit
278
378
492
663
931
1,280
1,680
1,883
2,288
2,438
Operating Income
-57
-63
-42
-186
142
299
265
391
597
600
EBITDA
-46
-49
-19
-74
213
376
377
565
916
945
Interest Expense
0
0
12
22
60
84
18
18
20
19
Depreciation
-
-
16
29
48
67
102
155
186
217
Income Before Tax
-57
-64
-48
-126
104
225
256
390
710
709
Income Tax Expense
0
0
1
0
3
-268
39
49
168
132
Net Income
-57
-65
-50
-127
101
493
216
341
541
576
Net Profit Margin
-14.33%
-11.44%
-6.99%
-12.32%
6.85%
25.62%
8.86%
11.73%
14.95%
14.29%

Dexcom, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
120
256
146
143
134
151
105
179
283
Operating Cash Flow
269
133
209
279
199
301
183
303
659
Investing Cash Flow
-179
414
74
-188
210
-303
100
-63
192
Financing Cash Flow
-637
-631
4
-1
-736
-1
12
-1
-175
Change in Cash
-551
-77
284
88
-316
-15
298
254
676

Dexcom, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-65
-50
-127
101
493
154
341
541
576
Operating Cash Flow
56
92
123
314
475
442
669
748
989
Investing Cash Flow
-55
-144
-139
-1,015
-1,018
-216
-521
-507
-207
Financing Cash Flow
8
399
710
10
912
10
-552
-318
-734
Change in Cash
8
347
695
-690
371
235
-410
-75
39

Mutual Funds that own Dexcom, Inc. Stock

Check out the Mutual Funds with significant holdings in Dexcom, Inc..

Global Institutional Holdings in Dexcom, Inc.

Funds
Holdings
Vanguard Group Inc
12.32%
BlackRock Inc
9.95%
State Street Corp
4.3%
Baillie Gifford & Co Limited.
4.26%
Jennison Associates LLC
2.94%

Dexcom, Inc. News & Key Events

    Insights on Dexcom, Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Dexcom, Inc. has shown positive revenue growth over the last three quarters. Revenue increased from $1.03 billion to $1.20 billion, reflecting an average increase of 7.4% per quarter.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Dexcom, Inc. has shown strong profit growth over the last three quarters. The company's net profit increased from $105.4 million to $283.8 million, which reflects an average growth of 39.0% each quarter.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, DXCM stock has moved up by 12.5%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Medtronic Plc has given 21.4% return, outperforming this stock by 37.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Boston Scientific Corp. has given 32.3% return, outperforming this stock by 76.4%

    About Dexcom, Inc.

    founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
    OrganisationDexcom, Inc.
    Headquarters6340 Sequence Drive, San Diego, CA, United States, 92121
    IndustryHealth Technology
    CEOMr. Jacob Steven Leach
    E-voting on sharesClick here to vote

    Key Management of Dexcom, Inc.

    Name

    Title

    Mr. Sean Christensen

    Vice President of Finance and Investor Relations

    Mr. Matthew Dolan

    Executive Vice President of Strategy & Corporate Development

    Mr. Kevin Ronald Sayer

    Executive Chairman & CEO (Leave of Absence)

    Mr. Jereme M. Sylvain CPA

    Executive VP, CFO & Chief Accounting Officer

    Mr. Michael Jon Brown

    Executive VP & Chief Legal Officer

    Mr. Donald M. Abbey

    Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs

    Mr. Jon Coleman

    Executive VP & Chief Commercial Officer

    Mr. Jacob Steven Leach

    Interim CEO, President & COO

    Ms. Sadie M. Stern

    Executive VP & Chief Human Resources Officer

    Mr. Girish Naganathan

    Executive VP & CTO

    FAQs

    What is Dexcom, Inc. share price today?

    Dexcom, Inc. share price today is $65.5 as on at the close of the market. Dexcom, Inc. share today touched a day high of $66.75 and a low of $65.23.

    What is the 52 week high and 52 week low for Dexcom, Inc. share?

    Dexcom, Inc. share touched a 52 week high of $93.25 on and a 52 week low of $54.11 on . Dexcom, Inc. stock price today i.e. is closed at $65.5,which is 29.76% down from its 52 week high and 21.05% up from its 52 week low.

    What is Dexcom, Inc.'s market capitalisation today?

    Dexcom, Inc. market capitalisation is $0.03T as on .

    How to invest in Dexcom, Inc. Stock (DXCM) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Dexcom, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dexcom, Inc. Shares that will get you 0.0229 shares as per Dexcom, Inc. share price of $65.5 per share as on December 6, 2025 at 2:29 am IST.

    What is the minimum amount required to buy Dexcom, Inc. Stock (DXCM) from India?

    Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹89.927 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹899.27 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Dexcom, Inc. share’s latest price of $65.5 as on December 6, 2025 at 2:29 am IST, you will get 0.1527 shares of Dexcom, Inc.. Learn more about fractional shares .

    What are the returns that Dexcom, Inc. has given to Indian investors in the last 5 years?

    Dexcom, Inc. stock has given -24.73% share price returns and 21.87% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?